TY  - GEN
AU  - Patnaik,Amita
AU  - Papadopoulos,Kyriakos P
AU  - Tolcher,Anthony W
AU  - Beeram,Muralidhar
AU  - Urien,Saïk
AU  - Schaaf,Larry J
AU  - Tahiri,Sanaa
AU  - Bekaii-Saab,Tanios
AU  - Lokiec,François M
AU  - Rezaï,Keyvan
AU  - Buchbinder,Aby
TI  - Phase I dose-escalation study of EZN-2208 (PEG-SN38), a novel conjugate of poly(ethylene) glycol and SN38, administered weekly in patients with advanced cancer
SN  - 1432-0843
PY  - 2013///0801
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Camptothecin
KW  - Data Interpretation, Statistical
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Infusions, Intravenous
KW  - Irinotecan
KW  - Male
KW  - Middle Aged
KW  - Neoplasms
KW  - drug therapy
KW  - Polyethylene Glycols
KW  - Prodrugs
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study
UR  - https://doi.org/10.1007/s00280-013-2149-2
ER  -